000 | 03054nam a22005295i 4500 | ||
---|---|---|---|
999 |
_c200458343 _d76555 |
||
003 | TR-AnTOB | ||
005 | 20231117143105.0 | ||
007 | cr nn 008mamaa | ||
008 | 220428s2022 si | s |||| 0|eng d | ||
020 | _a9789811654190 | ||
024 | 7 |
_a10.1007/978-981-16-5419-0 _2doi |
|
040 |
_aTR-AnTOB _beng _erda _cTR-AnTOB |
||
041 | _aeng | ||
060 | _aQU 93 | ||
072 | 7 |
_aMQW _2bicssc |
|
072 | 7 |
_aTEC059000 _2bisacsh |
|
072 | 7 |
_aMQW _2thema |
|
096 | _aQU93EBK | ||
245 | 1 | 0 |
_aGene Delivery _h[electronic resource] / _cedited by Huayu Tian, Xuesi Chen. |
250 | _a1st ed. 2022. | ||
264 | 1 |
_aSingapore : _bSpringer Nature Singapore : _bImprint: Springer, _c2022. |
|
300 | _a1 online resource | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aBiomaterial Engineering, _x2523-8817 |
|
505 | 0 | _aOverview on gene therapy -- Cationic liposome -- Functionalized peptide dendrimers -- Bioresponsive poly(amido amine)s -- Cationic polyphosphoesters -- Polysaccharide-based gene carriers -- Polypeptide-based gene carriers -- Fluorinated gene carriers -- Target gene delivery systems -- Cationic helical polypeptides -- Cyclic cationic polymers -- Cationic bolaamphiphile -- Chitosan-functionalized gene carriers -- Charge-reversal gene carriers -- Multifunctional envelope-type nanodevice -- Drug and gene co-delivery systems -- Oral delivery of gene therapy -- Gene therapy for brain diseases. | |
520 | _aGene delivery is a promising strategy for the specific treatment of numerous gene-associated human diseases by intentionally altering the gene expression in pathological cells. A successful clinical application of gene-based therapy depends on an efficient gene delivery system. Many efforts have been attempted to improve the safety and efficiency of gene-based therapies. Nanoparticles have been proved to be the most promising vehicles for clinical gene therapy due to their tunable size, shape, surface, and biological behaviors. In this volume, the recent developments of nanoparticles for clinical gene therapy will be identified and summarized. | ||
650 | 0 | _aBiomedical engineering. | |
650 | 0 | _aBiomaterials. | |
650 | 0 | _aMedical genetics. | |
650 | 1 | 4 | _aBiomedical Engineering and Bioengineering. |
650 | 2 | 4 | _aBiomaterials. |
650 | 2 | 4 | _aMedical Genetics. |
653 | 0 | _aBiomaterial engineering | |
700 | 1 |
_aTian, Huayu. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aChen, Xuesi. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
830 | 0 |
_aBiomaterial Engineering, _x2523-8817 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-981-16-5419-0 _3Springer eBooks _zOnline access link to the resource |
942 |
_2NLM _cEBK |